Discovering Impactful Medicines: Many Paths, Same Goal
Tuesday, April 23, 2024
12:00 pm - 1:00 pm
This event is a hybrid event hosted in Teams and in person at 3084 Health 2.
About the Event
In this presentation, Sharath Hegde will provide an overview of the drug-discovery process, its challenges and opportunities, and share his personal perspectives on the key drivers of success. He will also use historical precedents and draw on his own experience to illustrate the many paths one can take to discover impactful medicines.
About the Speaker
Sharath
S.
Hegde,
Ph.D.,
is
currently
Chief
Scientific
Officer
at
Congruence
Therapeutics
and
a
passionate
drug
hunter
who
has
participated
in
the
discovery
of
several
NCEs
including
the
marketed
medicines
Vibativ®
(telavancin),
Yupelri®
(revefenancin),
Aloxi®
(palanosetron)
and
others
in
late-stage
development
including
ampreloxetine
and
REC-3964.
After
obtaining
his
BPharm
and
MPharm
(Pharmacology)
from
the
University
of
Mumbai,
Sharath
moved
to
US
for
his
doctoral
studies
and
obtained
his
PhD
in
Pharmacology
from
the
University
of
Houston
(Class
of
1990)
under
the
mentorship
of
Dr.
Mustafa
Lokhandwala.
Sharath
has
over
30
years
of
leadership
experience
(Roche,
Theravance
Biopharma,
Recursion,
Herophilus)
in
strategic
and
tactical
aspects
of
drug-discovery
and
early
clinical
development.
He
has
been
trained
in
classical
‘integrated
pharmacology’.
He
possesses
extensive
experience
in
seeding
new
project
ideas
and
driving
the
discovery
of
first-in-class/best-in-class
drugs
in
multiple
therapeutic
areas
including
rare,
infectious,
cardiovascular,
respiratory,
genitourinary,
gastrointestinal,
neuroscience,
fibrosis,
oncology,
autoimmune
and
inflammatory
diseases.
He
is
the
co-author
of
over
50
scientific
publications.
- Location
- Health 2, Room 3084 and Online
- Cost
- Free
- Contact
- For more information, contact Nadine Peterson, DDI Coordinator